Lipoxins: resolutionary road

Lipoxin A4 Counterregulates GM-CSF Signaling in Eosinophilic Granulocytes

(2014) V. Starosta et al.   JOURNAL OF IMMUNOLOGY

Lipoxin A4 inhibits IL-1β-induced IL-8 and ICAM-1 expression in 1321N1 human astrocytoma cells

(2009) Yann Decker et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-inflammatory eicosanoid, lipoxin A4

(2009) Robert B. Zurier et al.   FASEB JOURNAL

Lipoxin A4: Anti-Inflammatory and Anti-Angiogenic Impact on Endothelial Cells

(2009) N. Baker et al.   JOURNAL OF IMMUNOLOGY

International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the Formyl Peptide Receptor (FPR) Family

(2009) R. D. Ye et al.   PHARMACOLOGICAL REVIEWS

Elevated Expressions of 15-Lipoxygenase and Lipoxin A4 in Children with Acute Poststreptococcal Glomerulonephritis

(2008) Sheng-Hua Wu et al.   AMERICAN JOURNAL OF PATHOLOGY

Airway Lipoxin A4Generation and Lipoxin A4Receptor Expression Are Decreased in Severe Asthma

(2008) Anna Planagumà et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Anti-Inflammatory and Proresolving Lipid Mediators

(2008) Charles N. Serhan et al.   Annual Review of Pathology-Mechanisms of Disease

Design and synthesis of benzo-lipoxin A4 analogs with enhanced stability and potent anti-inflammatory properties

(2008) Nicos A. Petasis et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

ATL-1, an analogue of aspirin-triggered lipoxin A4, is a potent inhibitor of several steps in angiogenesis induced by vascular endothelial growth factor

(2008) P F T Cezar-de-Mello et al.   BRITISH JOURNAL OF PHARMACOLOGY

Native and aspirin-triggered lipoxins control innate immunity by inducing proteasomal degradation of TRAF6

(2008) Fabiana S. Machado et al.   JOURNAL OF EXPERIMENTAL MEDICINE

A Novel Peptide Agonist of Formyl-Peptide Receptor-Like 1 (ALX) Displays Anti-Inflammatory and Cardioprotective Effects

(2008) I. Hecht et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Resolvin E1 regulates interleukin 23, interferon-γ and lipoxin A4 to promote the resolution of allergic airway inflammation

(2008) Oliver Haworth et al.   NATURE IMMUNOLOGY